Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM)

被引：0
|
作者：
Plum-Moerschel, Leona
Heise, Tim
Zijlstra, Eric
Lyby, Karsten
Wassermann, Karsten
Brondsted, Lise
Halberg, Inge Birk
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
380-OR
引用
收藏
页码：A100 / A100
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Ellison, Misoo C.
    Pong, Annpey
    Huyck, Susan
    Mancuso, James P.
    Terra, Steven G.
    Gantz, Ira
    DIABETES, 2019, 68
  • [22] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) and Concomitant Heart Failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A313 - A313
  • [23] Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Pong, Annpey
    Huyck, Susan
    Wu, Larry
    Mancuso, James P.
    Terra, Steven
    Lauring, Brett
    DIABETES, 2018, 67
  • [24] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    DIABETES, 2006, 55 : A111 - A111
  • [25] Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study
    Bipin Sethi
    Khalid Al-Rubeaan
    Mustafa Unubol
    Maria A. Mabunay
    Baptiste Berthou
    Valerie Pilorget
    Shireene R. Vethakkan
    Gustavo Frechtel
    Diabetes Therapy, 2022, 13 : 1395 - 1408
  • [26] Preference and Propensity: Evaluating Oral Treatment of Type 2 Diabetes (T2DM)
    Ritchey, Mary E.
    Chen, Yong
    Girman, Cynthia J.
    Brodovicz, Kimberly G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 199 - 200
  • [27] Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study
    Sethi, Bipin
    Al-Rubeaan, Khalid
    Unubol, Mustafa
    Mabunay, Maria A.
    Berthou, Baptiste
    Pilorget, Valerie
    Vethakkan, Shireene R.
    Frechtel, Gustavo
    DIABETES THERAPY, 2022, 13 (07) : 1395 - 1408
  • [28] Basal insulin persistence in Brazilian participants with T2DM
    Franco, Denise Reis
    Perez-Nieves, Magaly
    Ivanova, Jasmina I.
    Cao, Dachuang
    Caselato Vaz, Marcela Saturnino
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (10): : 1254 - 1264
  • [29] Characteristics of patients with type 2 diabetes mellitus (T2DM) on basal insulin who do not achieve glycaemic goals
    Brunton, S.
    Blonde, L.
    Chava, P.
    Zhou, R.
    Meyers, J.
    Davis, K.
    Dalal, M.
    DiGenio, A.
    DIABETOLOGIA, 2014, 57 : S54 - S54
  • [30] Treatment Persistence and Switch in German Patients with Type 2 Diabetes Mellitus (T2DM) after Initiating Basal Insulin
    Chou, Engels
    Dippel, Franz-Werner
    Chung, Hsing-Wen
    DIABETES, 2014, 63 : A403 - A403
12345